Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1 (PH1).
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 03, 2025
Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1.
Journal: Clinical pharmacokinetics
Published: June 05, 2025
Primary Hyperoxaluria Type 1: An Unexpected Diagnosis after Kidney Transplantation.
Journal: Kidney & blood pressure research
Published: March 09, 2025
Development, opportunities, and challenges of siRNA nucleic acid drugs.
Journal: Molecular therapy. Nucleic acids
Published: February 03, 2025
PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1.
Journal: Kidney international reports
Published: December 20, 2024
Concomitant Treatment With Lumasiran and Nedosiran in a Child With Primary Hyperoxaluria Type 1.
Journal: Kidney international reports
Published: December 02, 2024
Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study.
Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study.
Journal: Orphanet journal of rare diseases
Published: October 15, 2024
Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures.
Journal: Non-coding RNA
Published: October 03, 2024
Nedosiran in pediatric patients with PH1 and relatively preserved kidney function, a phase 2 study (PHYOX8).
Journal: Pediatric nephrology (Berlin, Germany)
Published: September 24, 2024
Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 16, 2024
A Targeted Release Capsule of Lanthanum Carbonate: a New Efficient Cheap Treatment for Primary Hyperoxalurias.
Journal: Kidney international reports
Published: August 05, 2024
Last Updated: 01/07/2026